Antibiotics. Targeting DnaN for tuberculosis therapy using novel griselimycins - Wikidata - awgldk - TriplyDB

Antibiotics. Targeting DnaN for tuberculosis therapy using novel griselimycins

Antibiotics. Targeting DnaN for tuberculosis therapy using novel griselimycins

http://www.wikidata.org/entity/Q27700967

about

New agents for the treatment of drug-resistant Mycobacterium tuberculosis Learning from the past for TB drug discovery in the future The Inosine Monophosphate Dehydrogenase, GuaB2, Is a Vulnerable New Bactericidal Drug Target for Tuberculosis.Target identification by image analysis Design, synthesis and structure-activity relationship study of wollamide B; a new potential anti TB agent.Recent contributions of structure-based drug design to the development of antibacterial compounds.Conformational Analysis of an Antibacterial Cyclodepsipeptide Active against Mycobacterium tuberculosis by a Combined ROE and RDC Analysis.Antimicrobial Potential of Bacteria Associated with Marine Sea Slugs from North Sulawesi, Indonesia.Color-Coded Super-Resolution Small-Molecule Imaging.New Structural Templates for Clinically Validated and Novel Targets in Antimicrobial Drug Research and Development.StreptomeDB 2.0--an extended resource of natural products produced by streptomycetes Identification of Thiotetronic Acid Antibiotic Biosynthetic Pathways by Target-directed Genome Mining Elucidation of the Teixobactin Pharmacophore.Tailored-pharmacophore model to enhance virtual screening and drug discovery: a case study on the identification of potential inhibitors against drug-resistant Mycobacterium tuberculosis (3R)-hydroxyacyl-ACP dehydratases.Synthetic Cyclic Peptomers as Type III Secretion System Inhibitors.The evolution of genome mining in microbes - a review.Toolbox for Antibiotics Discovery from Microorganisms.Structure of the sliding clamp from the fungal pathogen Aspergillus fumigatus (AfumPCNA) and interactions with Human p21.Strategies for the Discovery and Development of New Antibiotics from Natural Products: Three Case Studies.DNA replication proteins as potential targets for antimicrobials in drug-resistant bacterial pathogens.Recent Advances in Helicobacter pylori Replication: Possible Implications in Adaptation to a Pathogenic Lifestyle and Perspectives for Drug Design.Targeting Phenotypically Tolerant Mycobacterium tuberculosis.DNA Replication in Mycobacterium tuberculosis.Identification of aminopyrimidine-sulfonamides as potent modulators of Wag31-mediated cell elongation in mycobacteria.New structural classes of antituberculosis agents.Kunkel Lecture: Fundamental immunodeficiency and its correction.N-Acetylglucosamine-1-phosphate transferase, WecA, as a validated drug target in Mycobacterium tuberculosis.In vitro and in vivo activity of biapenem against drug-susceptible and rifampicin-resistant Mycobacterium tuberculosis.A Small Covalent Allosteric Inhibitor of Human Cytomegalovirus DNA Polymerase Subunit Interactions.Structural insight into β-Clamp and its interaction with DNA Ligase in Helicobacter pylori.Biosynthesis of methyl-proline containing griselimycins, natural products with anti-tuberculosis activity.Targeting DNA Replication and Repair for the Development of Novel Therapeutics against Tuberculosis.A chemocentric view of the natural product inventory.Caught between two proteins: a mycobacterial inhibitor challenges the mold.New antituberculous drugs derived from natural products: current perspectives and issues in antituberculous drug development.Mycobacterium tuberculosis Molecular Determinants of Infection, Survival Strategies, and Vulnerable Targets.Are highly morphed peptide frameworks lurking silently in microbial genomes valuable as next generation antibiotic scaffolds?Mapping the sequence-structure relationships of simple cyclic hexapeptides.ECBS & ICBS 2015 Joint Meeting: Bringing Chemistry to Life.DNA Replication Fidelity in the Mycobacterium tuberculosis Complex.

P2860

Q26751463-ACA34DB6-4467-4A3B-930F-3CA008352171 Q27485405-63CB1A98-2A48-4220-BABB-D26C94053D58 Q27728459-E377C0FF-88D2-427B-85B0-1A30F73B1704 Q28272139-50109456-E825-4056-BA90-5B23CC76A29C Q30313238-0757DCB1-C690-4D75-9CBF-A986A9A9825F Q30380194-747CEABA-6117-48C9-99CE-A0216385E117 Q32182961-023F29D2-E6E5-46C3-BD28-49AD27E99178 Q33794532-1E6BDDF5-9B64-4536-A013-33295C7A204A Q35963668-34A2D7D2-E1A1-4D49-80D6-48733F33FCA4 Q36153263-26671440-07BD-4978-9EA5-785D7B11AFD5 Q36435022-872B3BF6-55D7-4DDB-96CE-A45762724BE3 Q36592709-0EC2A3F8-985B-4156-98B9-3F001108AA3D Q37616543-1D0F046C-8BC3-41CD-990F-9C05586FBD54 Q38669024-686DA18D-CDAB-40B8-B472-74BA17AF8AB5 Q38698961-8AD48737-48F1-4802-ABE1-81FCC88FE69C Q38858040-ABDAF7B0-C58C-4D09-AC30-60BD6FD611B6 Q38867326-2FAA4248-DD91-43B3-8916-E0B8B8352067 Q38976873-6F187220-F117-4162-A0C0-0A8106950CF0 Q38980013-529BDFC7-02AD-4E58-AEAF-851134523F68 Q39078552-E91A1042-CA8F-4A24-BC7E-1EB777C08E19 Q39104009-1D09ADDD-2D1B-4089-BBE8-BDC444800C96 Q39149038-3570C94F-F4AD-43B4-8705-8E174E765439 Q39210590-F07FA1BD-9F41-4C0E-97E2-2D655CF571CE Q39345865-C7F0327D-48BA-4477-A1DC-52D1F018967F Q39362128-A7A36A32-4B04-4BAC-BE94-A634CBB2D874 Q39431238-F6740DE2-ED9F-4830-A727-F9C87B2B8AED Q40065984-8E00099C-21DA-470A-90AC-82871F228316 Q40187337-FC92CD5C-0CD6-46E3-9129-B11C438CAEEF Q40338385-C9274C6D-88AB-4BC5-A4EC-A9ED70822549 Q42375556-40B5E7DB-1188-44EA-B20B-DCFAB8071DC9 Q45269786-72D61EB4-7874-4DDD-A4EB-59160107E11B Q46478240-4E7F10D7-D31B-4708-9643-C02F0DB72DE4 Q46965285-040CCE55-206E-4030-AC92-9C82800CFF31 Q47124493-A9BD7ECD-2DDC-4FE3-B531-ACB2C94A2F7A Q47594312-B8E240B6-26E4-4DBD-92B4-A75F529C07F6 Q48124372-2DB54E57-553D-4BFC-B2BA-199092ECA796 Q48132456-67ED4F75-4DDA-49EA-95D7-FE7468C41918 Q48350502-9A151387-B992-4EE8-A6DC-EEBCA9D0826B Q48893627-07D36E84-E4F6-452C-BD50-BB51CEB3A288 Q50107946-949F0AD2-3D57-4BC0-BD3F-EED710B6ADDD

P2860

Antibiotics. Targeting DnaN for tuberculosis therapy using novel griselimycins

http://www.wikidata.org/entity/Q27700967

description

2015 nî lūn-bûn

@nan

2015 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Antibiotics. Targeting DnaN for tuberculosis therapy using novel griselimycins

@ast

Antibiotics. Targeting DnaN for tuberculosis therapy using novel griselimycins

@en

Antibiotics. Targeting DnaN for tuberculosis therapy using novel griselimycins

@nl

type

label

Antibiotics. Targeting DnaN for tuberculosis therapy using novel griselimycins

@ast

Antibiotics. Targeting DnaN for tuberculosis therapy using novel griselimycins

@en

Antibiotics. Targeting DnaN for tuberculosis therapy using novel griselimycins

@nl

prefLabel

Antibiotics. Targeting DnaN for tuberculosis therapy using novel griselimycins

@ast

Antibiotics. Targeting DnaN for tuberculosis therapy using novel griselimycins

@en

Antibiotics. Targeting DnaN for tuberculosis therapy using novel griselimycins

@nl

P1433

Q27700967-B2954B69-0C85-4043-AA90-ED7F978D1E43

P1476

Q27700967-56FC2AFF-557D-49B3-BC63-47D8111682D9

P2093

Q27700967-1CD31CA0-34E5-4917-A682-F7602C5A2CB9

Q27700967-1D8E1BE8-C69F-4B1E-B4EC-614DE882E838

Q27700967-209B3C1A-8433-4B1B-8844-B6A8604E271B

Q27700967-20C2EE9D-AF20-4D7D-A7CF-68EE16A7EA1B

Q27700967-22113C75-F7E4-410F-B081-F0DE6F8972B8

Q27700967-24DEE71F-96A6-4F4C-B66A-FD005901745A

Q27700967-2830AB93-50D4-41B8-B08D-ADD2115B179B

Q27700967-2A85B5F9-9F4F-46B1-AE55-DA39BDB061CF

Q27700967-2B9AE0E4-B5FD-43D4-9BF0-036CE84E09E4

Q27700967-3FA5AAFC-0DAB-4374-82F5-429A4529B931

P2860

Q27700967-0252FBB7-B328-4F42-9F68-799B9B144622

Q27700967-02A1AC63-43BE-4239-A6A3-E1FA0149A431

Q27700967-03B4132D-7CC9-4391-B1B0-5C10AE3BB325

Q27700967-1115599B-AF3B-4C27-B16B-C26E336125EF

Q27700967-140AA5D5-2070-47B0-B04A-B617AA703408

Q27700967-20478E4B-BD83-49C6-A8BE-3AAE70D67DB7

Q27700967-206A3BBB-B4DB-4C3A-A9AF-52D7B346EF1E

Q27700967-23C7EFE3-42D9-4371-BA0A-8FAC026E819F

Q27700967-2EA55868-8C7F-4B97-8929-662D4826F250

Q27700967-3C2A61AC-B821-4C90-BBF0-62BBA65D51CE

P304

Q27700967-0225923B-408E-452B-B8F9-F2FE3158DDBE

P31

Q27700967-285019BC-E7C5-49E9-8C72-441E92AB3480

P3181

Q27700967-7B6DFE5D-CE39-4153-ACC6-C5EB0E1D0946

P356

Q27700967-7E19BAA9-43B1-4393-B930-65F76FAF29A0

P407

Q27700967-13D3E443-6916-400E-AF89-EA972D921F2E

P433

Q27700967-347DCDCA-3FE4-40F3-9888-4E62654EB57F

P478

Q27700967-AE4F763D-103B-4F03-9646-FF2E38A59210

P50

Q27700967-0C4CE482-3302-44A5-A2EA-BCA4291B3101

Q27700967-76DEE85F-7855-4D32-B883-50FC3B9F2107

Q27700967-C0EB334B-0295-483D-840A-0A2CC4C11DB0

P577

Q27700967-568F055C-C817-4187-A6D1-9FD797A6742D

P5875

Q27700967-8C3A7BBC-76EB-4774-8B2B-BEB2338A1914

P698

Q27700967-995116A1-CB1C-4D82-A101-F6C8AE85EE72

P921

Q27700967-0710FE49-93E8-458E-821C-511BA603FFBC

Q27700967-8734CECA-2091-429B-89B3-FD9353A085A3

P3181

P356

SCIENCE.AAA4690

P1433

P1476

Antibiotics. Targeting DnaN for tuberculosis therapy using novel griselimycins

@en

P2093

Angela Kling

http://www.w3.org/2001/XMLSchema#string

Armin Bauer

http://www.w3.org/2001/XMLSchema#string

Christine Lair

http://www.w3.org/2001/XMLSchema#string

Claudia König

http://www.w3.org/2001/XMLSchema#string

Deepak V Almeida

http://www.w3.org/2001/XMLSchema#string

Dirk W Heinz

http://www.w3.org/2001/XMLSchema#string

Eric Nuermberger

http://www.w3.org/2001/XMLSchema#string

Evelyne Fontaine

http://www.w3.org/2001/XMLSchema#string

Florence Bordon-Pallier

http://www.w3.org/2001/XMLSchema#string

Gilles Courtemanche

http://www.w3.org/2001/XMLSchema#string

P2860

Electrostatics of nanosystems: application to microtubules and the ribosome

PHENIX: a comprehensive Python-based system for macromolecular structure solution

ExPASy: The proteomics server for in-depth protein knowledge and analysis

Basic local alignment search tool

Structural basis for recruitment of translesion DNA polymerase Pol IV/DinB to the -clamp

Structural and biochemical analysis of sliding clamp/ligand interactions suggest a competition between replicative and translesion DNA polymerases

Structure of a small-molecule inhibitor of a DNA polymerase sliding clamp

Crystal structure of DNA polymerase III β sliding clamp from Mycobacterium tuberculosis

Binding inhibitors of the bacterial sliding clamp by design

Towards a new tuberculosis drug: pyridomycin - nature's isoniazid

P304

1106-1112

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4302015

http://www.w3.org/2001/XMLSchema#string

P356

10.1126/SCIENCE.AAA4690

http://www.w3.org/2001/XMLSchema#string

P407

P433

6239

http://www.w3.org/2001/XMLSchema#string

P478

348

http://www.w3.org/2001/XMLSchema#string

P50

Mark Brönstrup

Nicole C Ammerman

P577

2015-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

277778571

http://www.w3.org/2001/XMLSchema#string

P698

26045430

http://www.w3.org/2001/XMLSchema#string

P921

Akafuba bulwadde